Revisi per 14 Januari 2021 10.41 sunting Adhiwangsa (bicara \| kontrib) Pengecualian blokir IP, Peninjau 661 suntingan →‎Status pengembangan vaksin: Gam-COVID-Vac Tag: VisualEditor ← Revisi sebelumnya		Revisi per 14 Januari 2021 13.27 sunting balikkan Adhiwangsa (bicara \| kontrib) Pengecualian blokir IP, Peninjau 661 suntingan k →‎Status pengembangan vaksin Tag: VisualEditor Revisi selanjutnya →
Baris 125: [[Sinovac Biotech\|Sinovac]] \| * Tiongkok (''awal'')<ref>{{Cite news\|last=\|first=\|date=6 Desember 2020\|title=China prepares large-scale rollout of domestically-produced coronavirus vaccines\|url=https://www.theglobeandmail.com/world/article-china-prepares-large-scale-rollout-of-domestically-produced/\|work=The Globe and Mail\|access-date=14 Januari 2021}}</ref> * Tiongkok (''awal'') * Bolivia * Indonesia<ref>{{Cite news\|last=\|first=\|date=11 Januari 2021\|title=BPOM Resmi Terbitkan Izin Darurat Vaksin Corona Sinovac\|url=https://www.cnnindonesia.com/nasional/20201221162146-20-584828/bpom-resmi-terbitkan-izin-darurat-vaksin-corona-sinovac\|work=CNN Indonesia\|access-date=14 Januari 2021}}</ref> * Indonesia * Turki<ref>{{Cite news\|last=\|first=\|date=14 Januari 2021\|title=Turki Restui Penggunaan Darurat Vaksin Sinovac\|url=https://www.cnnindonesia.com/internasional/20210114090942-120-593514/turki-restui-penggunaan-darurat-vaksin-sinovac\|work=CNN Indonesia\|access-date=14 Januari 2021}}</ref> * Turki \| \|- Baris 136: [[Universitas Oxford]], [[AstraZeneca]], [[Koalisi Inovasi Kesiapsiagaan Epidemi\|CEPI]] \| * Britania Raya<ref>{{Cite web\|last=\|first=\|date=30 Desember 2020\|title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator\|url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator\|publisher=Department of Health and Social Care\|access-date=14 Januari 2021}}</ref> * Britania Raya * Argentina<ref>{{Cite news\|last=Laing\|first=Aislinn\|date=31 Desember 2020\|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca\|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P\|work=Reuters\|access-date=14 Januari 2021}}</ref> * Argentina * India<ref>{{Cite news\|last=Pasricha\|first=Arjana\|date=3 Januari 2021\|title=India Approves AstraZeneca and Locally Developed Vaccine\|url=https://www.voanews.com/covid-19-pandemic/india-approves-astrazeneca-and-locally-developed-vaccine\|work=VOA News\|access-date=14 Januari 2021}}</ref> * India * El Salvador<ref>{{Cite news\|last=\|first=\|date=31 Desember 2020\|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine\|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ\|work=Reuters\|access-date=14 Januari 2021}}</ref> * El Salvador * Republik Dominika * Meksiko<ref>{{Cite news\|last=\|first=\|date=5 Januari 2021\|title=Mexico approves AstraZeneca vaccine for emergency use\|url=https://apnews.com/article/health-coronavirus-pandemic-mexico-fc06d8d29aa28093488ccd6a40997d7d\|work=AP News\|access-date=14 Januari 2021}}</ref> * Meksiko * Bangladesh<ref>{{Cite news\|last=\|first=\|date=4 Januari 2021\|title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use\|url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381\|work=The Daily Star\|access-date=14 Januari 2021}}</ref> * Bangladesh \| \|-

Vaksin Covid-19: Perbedaan antara revisi